CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 13.80
  • +0.52+3.92%
Market Closed Jan 14 15:00 CST
3.86BMarket Cap23.55P/E (TTM)

Newland Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.62%537.24M
18.74%396.76M
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
Operating revenue
9.62%537.24M
18.74%396.76M
6.98%184.58M
3.84%651.44M
9.33%490.1M
-3.78%334.15M
7.54%172.54M
22.09%627.36M
37.06%448.29M
33.82%347.27M
Other operating revenue
----
-10.19%2.94M
----
23.34%7.59M
----
8.61%3.28M
----
25.30%6.15M
----
31.14%3.02M
Total operating cost
8.67%388.85M
13.32%273.44M
-0.48%127.02M
1.45%492.35M
2.80%357.81M
-8.12%241.3M
7.00%127.64M
30.11%485.33M
43.79%348.05M
43.60%262.62M
Operating cost
9.10%316.91M
13.40%225.28M
-2.05%104.17M
-2.99%391.92M
-0.56%290.47M
-12.12%198.66M
2.19%106.36M
31.25%404.01M
50.79%292.1M
52.08%226.06M
Operating tax surcharges
-22.56%4.19M
-11.18%3.26M
-4.59%1.62M
-5.89%6.57M
-2.21%5.41M
-17.04%3.68M
-15.04%1.69M
9.12%6.99M
32.64%5.53M
34.68%4.43M
Operating expense
45.79%3.66M
53.28%2.08M
36.48%821.58K
80.23%4.86M
44.81%2.51M
15.82%1.36M
19.32%601.97K
28.32%2.7M
26.55%1.73M
43.74%1.17M
Administration expense
-9.12%27.95M
-5.94%18.65M
-14.55%9.57M
9.66%39.62M
31.54%30.76M
30.01%19.82M
58.23%11.2M
22.65%36.13M
5.42%23.38M
-2.29%15.25M
Financial expense
-123.11%-2.09M
-259.63%-1.77M
-406.64%-1.15M
-147.19%-2.6M
-119.30%-934.65K
-114.42%-491.71K
-113.92%-226.29K
-17.28%5.5M
-0.49%4.84M
10.34%3.41M
-Interest expense (Financial expense)
-63.84%189.7K
-77.35%175.96K
-43.41%33.22K
-98.07%132.85K
-90.11%524.59K
-78.45%776.94K
-96.48%58.7K
2.63%6.88M
9.46%5.31M
19.68%3.61M
-Interest Income (Financial expense)
-55.49%-2.21M
-96.54%-1.84M
-223.10%-1.14M
-130.40%-2.7M
-298.02%-1.42M
-397.40%-936.9K
-304.71%-353.17K
-357.88%-1.17M
-102.44%-357.21K
-132.21%-188.36K
Research and development
29.12%38.23M
41.92%25.94M
49.59%11.99M
73.19%51.96M
44.65%29.61M
48.54%18.28M
99.95%8.02M
45.72%30M
29.92%20.47M
7.54%12.3M
Credit Impairment Loss
-84.82%419.15K
-174.84%-2.38M
-119.23%-659.41K
257.71%3.52M
583.45%2.76M
175.70%3.18M
263.13%3.43M
79.94%-2.23M
-153.50%-571.06K
-183.41%-4.2M
Asset Impairment Loss
-384.45%-2.85M
-607.55%-1.76M
---862.61K
---914.6K
---588.01K
---248.41K
----
----
----
----
Other net revenue
-24.30%12.72M
-51.60%6.05M
-64.54%2.93M
3,959.30%23.67M
5,006.69%16.8M
468.07%12.5M
518.20%8.26M
107.03%583.09K
-90.37%329.07K
-86,133.04%-3.4M
Fair value change income
351.29%643K
110.27%74.86K
45.59%-228.62K
-96.97%41.06K
-0.36%142.48K
-783.30%-728.81K
-779.42%-420.17K
715.67%1.36M
39.07%143K
191.21%106.66K
Invest income
-24.16%10.42M
-26.87%7.28M
-30.21%3.62M
10,030.79%16.92M
--13.74M
--9.96M
--5.18M
7,725.57%167.03K
----
----
Asset deal income
----
----
----
115.12%66.94K
----
----
----
-114.11%-442.73K
---442.73K
----
Other revenue
445.35%4.09M
742.86%2.83M
1,398.25%1.06M
132.58%4.04M
-37.53%749.51K
-51.85%335.34K
10.25%70.97K
-39.46%1.74M
-46.51%1.2M
-51.59%696.44K
Operating profit
8.07%161.12M
22.80%129.37M
13.77%60.49M
28.14%182.76M
48.24%149.09M
29.65%105.35M
35.68%53.17M
7.63%142.62M
13.72%100.57M
6.04%81.25M
Add:Non operating Income
-75.83%11.37K
-52.42%8.57K
-89.88%1.7K
-98.00%13.97K
-93.23%47.06K
-97.41%18.02K
-88.61%16.8K
1,695.44%698.42K
4,238.03%695.24K
5,302.62%694.98K
Less:Non operating expense
19.99%1.11M
260.40%674.37K
28.72%173.95K
269.54%1.61M
269.63%929.01K
141.22%187.12K
--135.14K
-29.62%434.77K
-54.02%251.34K
-80.81%77.57K
Total profit
7.97%160.01M
22.37%128.7M
13.70%60.32M
26.79%181.16M
46.72%148.21M
28.47%105.18M
34.87%53.05M
8.30%142.88M
14.91%101.01M
7.39%81.87M
Less:Income tax cost
44.54%18.14M
52.01%18.2M
-24.87%4.93M
114.45%23.96M
3.41%12.55M
13.41%11.97M
21.09%6.56M
-34.70%11.17M
9.32%12.14M
4.09%10.56M
Net profit
4.59%141.88M
18.56%110.5M
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
Net profit from continuing operation
4.59%141.88M
18.56%110.5M
----
19.36%157.2M
52.63%135.66M
30.70%93.2M
----
14.70%131.71M
--88.88M
--71.31M
Less:Minority Profit
106.45%66.09K
-95.83%-999.9K
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
Net profit of parent company owners
3.75%141.81M
18.98%111.5M
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
Earning per share
Basic earning per share
3.75%0.5064
21.21%0.4
21.74%0.28
-8.14%0.79
-45.34%0.4881
-54.17%0.33
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
Diluted earning per share
3.75%0.5064
21.21%0.4
21.74%0.28
-8.14%0.79
-45.34%0.4881
-54.17%0.33
-32.35%0.23
-25.22%0.86
15.96%0.8929
9.09%0.72
Other composite income
Total composite income
4.59%141.88M
18.56%110.5M
19.15%55.39M
19.36%157.2M
52.63%135.66M
30.70%93.2M
37.07%46.49M
14.70%131.71M
15.72%88.88M
7.90%71.31M
Total composite income of parent company owners
3.75%141.81M
18.98%111.5M
19.69%55.92M
20.16%158.98M
53.07%136.68M
30.91%93.71M
37.19%46.72M
15.07%132.3M
16.13%89.29M
8.30%71.58M
Total composite income of minority owners
106.45%66.09K
-95.83%-999.9K
-128.32%-530.5K
-197.82%-1.78M
-147.86%-1.03M
-86.72%-510.6K
-67.19%-232.35K
-286.25%-596.75K
-391.37%-413.62K
-9,096.05%-273.46K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.62%537.24M18.74%396.76M6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M
Operating revenue 9.62%537.24M18.74%396.76M6.98%184.58M3.84%651.44M9.33%490.1M-3.78%334.15M7.54%172.54M22.09%627.36M37.06%448.29M33.82%347.27M
Other operating revenue -----10.19%2.94M----23.34%7.59M----8.61%3.28M----25.30%6.15M----31.14%3.02M
Total operating cost 8.67%388.85M13.32%273.44M-0.48%127.02M1.45%492.35M2.80%357.81M-8.12%241.3M7.00%127.64M30.11%485.33M43.79%348.05M43.60%262.62M
Operating cost 9.10%316.91M13.40%225.28M-2.05%104.17M-2.99%391.92M-0.56%290.47M-12.12%198.66M2.19%106.36M31.25%404.01M50.79%292.1M52.08%226.06M
Operating tax surcharges -22.56%4.19M-11.18%3.26M-4.59%1.62M-5.89%6.57M-2.21%5.41M-17.04%3.68M-15.04%1.69M9.12%6.99M32.64%5.53M34.68%4.43M
Operating expense 45.79%3.66M53.28%2.08M36.48%821.58K80.23%4.86M44.81%2.51M15.82%1.36M19.32%601.97K28.32%2.7M26.55%1.73M43.74%1.17M
Administration expense -9.12%27.95M-5.94%18.65M-14.55%9.57M9.66%39.62M31.54%30.76M30.01%19.82M58.23%11.2M22.65%36.13M5.42%23.38M-2.29%15.25M
Financial expense -123.11%-2.09M-259.63%-1.77M-406.64%-1.15M-147.19%-2.6M-119.30%-934.65K-114.42%-491.71K-113.92%-226.29K-17.28%5.5M-0.49%4.84M10.34%3.41M
-Interest expense (Financial expense) -63.84%189.7K-77.35%175.96K-43.41%33.22K-98.07%132.85K-90.11%524.59K-78.45%776.94K-96.48%58.7K2.63%6.88M9.46%5.31M19.68%3.61M
-Interest Income (Financial expense) -55.49%-2.21M-96.54%-1.84M-223.10%-1.14M-130.40%-2.7M-298.02%-1.42M-397.40%-936.9K-304.71%-353.17K-357.88%-1.17M-102.44%-357.21K-132.21%-188.36K
Research and development 29.12%38.23M41.92%25.94M49.59%11.99M73.19%51.96M44.65%29.61M48.54%18.28M99.95%8.02M45.72%30M29.92%20.47M7.54%12.3M
Credit Impairment Loss -84.82%419.15K-174.84%-2.38M-119.23%-659.41K257.71%3.52M583.45%2.76M175.70%3.18M263.13%3.43M79.94%-2.23M-153.50%-571.06K-183.41%-4.2M
Asset Impairment Loss -384.45%-2.85M-607.55%-1.76M---862.61K---914.6K---588.01K---248.41K----------------
Other net revenue -24.30%12.72M-51.60%6.05M-64.54%2.93M3,959.30%23.67M5,006.69%16.8M468.07%12.5M518.20%8.26M107.03%583.09K-90.37%329.07K-86,133.04%-3.4M
Fair value change income 351.29%643K110.27%74.86K45.59%-228.62K-96.97%41.06K-0.36%142.48K-783.30%-728.81K-779.42%-420.17K715.67%1.36M39.07%143K191.21%106.66K
Invest income -24.16%10.42M-26.87%7.28M-30.21%3.62M10,030.79%16.92M--13.74M--9.96M--5.18M7,725.57%167.03K--------
Asset deal income ------------115.12%66.94K-------------114.11%-442.73K---442.73K----
Other revenue 445.35%4.09M742.86%2.83M1,398.25%1.06M132.58%4.04M-37.53%749.51K-51.85%335.34K10.25%70.97K-39.46%1.74M-46.51%1.2M-51.59%696.44K
Operating profit 8.07%161.12M22.80%129.37M13.77%60.49M28.14%182.76M48.24%149.09M29.65%105.35M35.68%53.17M7.63%142.62M13.72%100.57M6.04%81.25M
Add:Non operating Income -75.83%11.37K-52.42%8.57K-89.88%1.7K-98.00%13.97K-93.23%47.06K-97.41%18.02K-88.61%16.8K1,695.44%698.42K4,238.03%695.24K5,302.62%694.98K
Less:Non operating expense 19.99%1.11M260.40%674.37K28.72%173.95K269.54%1.61M269.63%929.01K141.22%187.12K--135.14K-29.62%434.77K-54.02%251.34K-80.81%77.57K
Total profit 7.97%160.01M22.37%128.7M13.70%60.32M26.79%181.16M46.72%148.21M28.47%105.18M34.87%53.05M8.30%142.88M14.91%101.01M7.39%81.87M
Less:Income tax cost 44.54%18.14M52.01%18.2M-24.87%4.93M114.45%23.96M3.41%12.55M13.41%11.97M21.09%6.56M-34.70%11.17M9.32%12.14M4.09%10.56M
Net profit 4.59%141.88M18.56%110.5M19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M
Net profit from continuing operation 4.59%141.88M18.56%110.5M----19.36%157.2M52.63%135.66M30.70%93.2M----14.70%131.71M--88.88M--71.31M
Less:Minority Profit 106.45%66.09K-95.83%-999.9K-128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K
Net profit of parent company owners 3.75%141.81M18.98%111.5M19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M
Earning per share
Basic earning per share 3.75%0.506421.21%0.421.74%0.28-8.14%0.79-45.34%0.4881-54.17%0.33-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72
Diluted earning per share 3.75%0.506421.21%0.421.74%0.28-8.14%0.79-45.34%0.4881-54.17%0.33-32.35%0.23-25.22%0.8615.96%0.89299.09%0.72
Other composite income
Total composite income 4.59%141.88M18.56%110.5M19.15%55.39M19.36%157.2M52.63%135.66M30.70%93.2M37.07%46.49M14.70%131.71M15.72%88.88M7.90%71.31M
Total composite income of parent company owners 3.75%141.81M18.98%111.5M19.69%55.92M20.16%158.98M53.07%136.68M30.91%93.71M37.19%46.72M15.07%132.3M16.13%89.29M8.30%71.58M
Total composite income of minority owners 106.45%66.09K-95.83%-999.9K-128.32%-530.5K-197.82%-1.78M-147.86%-1.03M-86.72%-510.6K-67.19%-232.35K-286.25%-596.75K-391.37%-413.62K-9,096.05%-273.46K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme High Throughput
High Throughput
Intraday+4.30%